Balversa

Balversa (Erdafitinib) is an oral medication used to treat specific types of cancer. This advanced therapy targets genetic mutations to help manage certain conditions. Learn more about Balversa's uses and effects.

Balversa is primarily used in the treatment of advanced urothelial carcinoma, a type of bladder cancer. It is designed for patients with specific genetic mutations, such as FGFR2 or FGFR3. The medication works by targeting these mutations to slow down the growth of cancer cells. Patients often wonder, 'What is Balversa used for?' and the answer lies in its targeted approach to cancer treatment.

Common effects of Balversa may include fatigue, nausea, and changes in appetite. Some users also report stomach pain or diarrhea. These effects can vary from person to person and may not affect everyone who takes the medication. It's important to monitor how your body responds to Balversa and consult a healthcare provider if any effects are concerning.

Balversa should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should discuss the use of Balversa with their healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Balversa may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with your healthcare provider before starting Balversa. Alcohol and other substances may also interact with Balversa, so it's best to avoid them unless advised otherwise by a healthcare professional.